Federal Court invalidates patent

The Federal Court’s reasons in Amgen Canada Inc v Mylan Pharmaceuticals ULC are a rare instance of the Court invalidating a patent covering a chemical compound on prior art grounds.
What are the implications of this case?


2015 trends – privacy class actions

This past year saw a number of case decisions that reduce or eliminate potential obstacles to privacy.
Read about key case decisions


Key takeaways from TPP’s legal text

Insights on the salient aspects of the Trans-Pacific Partnership’s provisions.
Learn about the TPP’s impacts


Pension innovation in Canada

Legislative amendments across Canada are facilitating changes in pension funding and design.
What are the latest developments?

Stay up to date

Subscribe to updates from Osler

Keep informed of changes in the Canadian legal market that could impact your business
Subscribe now